华润双鹤(600062.SH)：氯化钾注射液获得药品补充申请批准通知书

Core Viewpoint - China Resources Double Crane Pharmaceutical Co., Ltd. (华润双鹤) announced that its wholly-owned subsidiary, Anhui Double Crane Pharmaceutical Co., Ltd. (安徽双鹤), received the approval notice for the supplementary application of potassium chloride injection from the National Medical Products Administration (国家药监局) [1] Group 1 - The approval includes an additional specification of 10ml:1.5g for potassium chloride injection, which has passed the consistency evaluation of generic drug quality and efficacy [1] - Potassium chloride injection is used for the treatment and prevention of hypokalemia, particularly when oral potassium supplementation is not feasible [1] - The approval is expected to enhance future market sales and competition, while also providing valuable experience for subsequent consistency evaluations of generic drugs [1]